SK165999A3 - A transurethral device - Google Patents
A transurethral device Download PDFInfo
- Publication number
- SK165999A3 SK165999A3 SK1659-99A SK165999A SK165999A3 SK 165999 A3 SK165999 A3 SK 165999A3 SK 165999 A SK165999 A SK 165999A SK 165999 A3 SK165999 A3 SK 165999A3
- Authority
- SK
- Slovakia
- Prior art keywords
- medicament
- channel
- piston
- urethra
- transurethral
- Prior art date
Links
- 239000003814 drug Substances 0.000 claims abstract description 151
- 229940079593 drug Drugs 0.000 claims abstract description 55
- 210000003708 urethra Anatomy 0.000 claims abstract description 49
- 238000003780 insertion Methods 0.000 claims abstract description 26
- 230000037431 insertion Effects 0.000 claims abstract description 26
- 241001465754 Metazoa Species 0.000 claims abstract description 12
- 239000012530 fluid Substances 0.000 claims abstract description 8
- 201000001881 impotence Diseases 0.000 claims description 33
- 208000010228 Erectile Dysfunction Diseases 0.000 claims description 21
- 238000006073 displacement reaction Methods 0.000 claims description 10
- 239000007788 liquid Substances 0.000 claims description 9
- BNRNXUUZRGQAQC-UHFFFAOYSA-N sildenafil Chemical compound CCCC1=NN(C)C(C(N2)=O)=C1N=C2C(C(=CC=1)OCC)=CC=1S(=O)(=O)N1CCN(C)CC1 BNRNXUUZRGQAQC-UHFFFAOYSA-N 0.000 claims description 8
- LNEPOXFFQSENCJ-UHFFFAOYSA-N haloperidol Chemical compound C1CC(O)(C=2C=CC(Cl)=CC=2)CCN1CCCC(=O)C1=CC=C(F)C=C1 LNEPOXFFQSENCJ-UHFFFAOYSA-N 0.000 claims description 6
- 239000000314 lubricant Substances 0.000 claims description 6
- 230000001050 lubricating effect Effects 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- GMVPRGQOIOIIMI-UHFFFAOYSA-N (8R,11R,12R,13E,15S)-11,15-Dihydroxy-9-oxo-13-prostenoic acid Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CCCCCCC(O)=O GMVPRGQOIOIIMI-UHFFFAOYSA-N 0.000 claims description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 3
- 108010003205 Vasoactive Intestinal Peptide Proteins 0.000 claims description 3
- 102400000015 Vasoactive intestinal peptide Human genes 0.000 claims description 3
- 229960000711 alprostadil Drugs 0.000 claims description 3
- HSWPZIDYAHLZDD-UHFFFAOYSA-N atipamezole Chemical compound C1C2=CC=CC=C2CC1(CC)C1=CN=CN1 HSWPZIDYAHLZDD-UHFFFAOYSA-N 0.000 claims description 3
- 229960003002 atipamezole Drugs 0.000 claims description 3
- 229910052791 calcium Inorganic materials 0.000 claims description 3
- 239000011575 calcium Substances 0.000 claims description 3
- ZPEIMTDSQAKGNT-UHFFFAOYSA-N chlorpromazine Chemical compound C1=C(Cl)C=C2N(CCCN(C)C)C3=CC=CC=C3SC2=C1 ZPEIMTDSQAKGNT-UHFFFAOYSA-N 0.000 claims description 3
- 229960001076 chlorpromazine Drugs 0.000 claims description 3
- 229940052760 dopamine agonists Drugs 0.000 claims description 3
- 239000003136 dopamine receptor stimulating agent Substances 0.000 claims description 3
- 229960003133 ergot alkaloid Drugs 0.000 claims description 3
- 229960003878 haloperidol Drugs 0.000 claims description 3
- 239000003887 narcotic antagonist Substances 0.000 claims description 3
- 150000002823 nitrates Chemical class 0.000 claims description 3
- 229940094443 oxytocics prostaglandins Drugs 0.000 claims description 3
- IENZQIKPVFGBNW-UHFFFAOYSA-N prazosin Chemical compound N=1C(N)=C2C=C(OC)C(OC)=CC2=NC=1N(CC1)CCN1C(=O)C1=CC=CO1 IENZQIKPVFGBNW-UHFFFAOYSA-N 0.000 claims description 3
- 229960001289 prazosin Drugs 0.000 claims description 3
- GMVPRGQOIOIIMI-DWKJAMRDSA-N prostaglandin E1 Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O GMVPRGQOIOIIMI-DWKJAMRDSA-N 0.000 claims description 3
- 150000003180 prostaglandins Chemical class 0.000 claims description 3
- 229960003310 sildenafil Drugs 0.000 claims description 3
- 230000002227 vasoactive effect Effects 0.000 claims description 3
- 229940044551 receptor antagonist Drugs 0.000 claims description 2
- 239000002464 receptor antagonist Substances 0.000 claims description 2
- 230000001419 dependent effect Effects 0.000 claims 3
- BLGXFZZNTVWLAY-SCYLSFHTSA-N yohimbine Chemical compound C1=CC=C2C(CCN3C[C@@H]4CC[C@H](O)[C@@H]([C@H]4C[C@H]33)C(=O)OC)=C3NC2=C1 BLGXFZZNTVWLAY-SCYLSFHTSA-N 0.000 claims 1
- 229940124597 therapeutic agent Drugs 0.000 description 9
- 238000012377 drug delivery Methods 0.000 description 4
- 239000004606 Fillers/Extenders Substances 0.000 description 3
- 238000011109 contamination Methods 0.000 description 3
- 208000004362 Penile Induration Diseases 0.000 description 2
- 208000020758 Peyronie disease Diseases 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 238000009513 drug distribution Methods 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 210000003899 penis Anatomy 0.000 description 2
- 201000011264 priapism Diseases 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 206010057040 Temperature intolerance Diseases 0.000 description 1
- 239000000670 adrenergic alpha-2 receptor antagonist Substances 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000008543 heat sensitivity Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000018052 penile erection Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 238000011200 topical administration Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000000982 vasogenic effect Effects 0.000 description 1
- 229940094720 viagra Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/06—Body-piercing guide needles or the like
- A61M25/0662—Guide tubes
- A61M2025/0681—Systems with catheter and outer tubing, e.g. sheath, sleeve or guide tube
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Anesthesiology (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9702147A SE9702147D0 (sv) | 1997-06-05 | 1997-06-05 | A transurethral device |
| PCT/SE1998/001029 WO1998055176A1 (en) | 1997-06-05 | 1998-05-29 | A transurethral device |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK165999A3 true SK165999A3 (en) | 2000-07-11 |
Family
ID=20407263
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK1659-99A SK165999A3 (en) | 1997-06-05 | 1998-05-29 | A transurethral device |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0986417A1 (is) |
| JP (1) | JP2002502290A (is) |
| KR (1) | KR20010049181A (is) |
| CN (1) | CN1263476A (is) |
| AR (1) | AR012857A1 (is) |
| AU (1) | AU8045398A (is) |
| BR (1) | BR9809552A (is) |
| CA (1) | CA2291612A1 (is) |
| EE (1) | EE9900563A (is) |
| HU (1) | HUP0001919A3 (is) |
| IL (1) | IL133041A0 (is) |
| IS (1) | IS5271A (is) |
| NO (1) | NO995962L (is) |
| PL (1) | PL337450A1 (is) |
| SE (1) | SE9702147D0 (is) |
| SK (1) | SK165999A3 (is) |
| TR (1) | TR199902959T2 (is) |
| WO (1) | WO1998055176A1 (is) |
| ZA (1) | ZA984537B (is) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1237593A1 (en) * | 1999-11-22 | 2002-09-11 | Epix Medical, Inc. | Imaging sexual response |
| WO2005000316A1 (ja) * | 2003-06-25 | 2005-01-06 | Cardiovascular Institute, Ltd. | 性交機能改善用外用製剤 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR562564A (fr) * | 1923-02-22 | 1923-11-14 | Pose-crayon pour l'usage intra-utérin et intra-urétral | |
| CH302318A (de) * | 1952-05-09 | 1954-10-15 | Wolfgang Dr Med Bachmann | Medizinisches Gerät. |
| US3256884A (en) * | 1963-04-15 | 1966-06-21 | Hill | Injection device for artificial insemination having a disposable dispensing capsule with detachable actuator |
| JPH034282Y2 (is) * | 1986-09-16 | 1991-02-04 | ||
| US5482039A (en) * | 1994-03-25 | 1996-01-09 | Vivus, Inc. | Process for diagnosing erectile dysfunction, and related methods of treatment |
-
1997
- 1997-06-05 SE SE9702147A patent/SE9702147D0/xx unknown
-
1998
- 1998-05-26 AR ARP980102435A patent/AR012857A1/es unknown
- 1998-05-27 ZA ZA984537A patent/ZA984537B/xx unknown
- 1998-05-29 KR KR1019997011399A patent/KR20010049181A/ko not_active Withdrawn
- 1998-05-29 EE EEP199900563A patent/EE9900563A/xx unknown
- 1998-05-29 SK SK1659-99A patent/SK165999A3/sk unknown
- 1998-05-29 JP JP50224699A patent/JP2002502290A/ja active Pending
- 1998-05-29 TR TR1999/02959T patent/TR199902959T2/xx unknown
- 1998-05-29 CA CA002291612A patent/CA2291612A1/en not_active Abandoned
- 1998-05-29 BR BR9809552-8A patent/BR9809552A/pt not_active Application Discontinuation
- 1998-05-29 CN CN98805785A patent/CN1263476A/zh active Pending
- 1998-05-29 AU AU80453/98A patent/AU8045398A/en not_active Abandoned
- 1998-05-29 IL IL13304198A patent/IL133041A0/xx unknown
- 1998-05-29 WO PCT/SE1998/001029 patent/WO1998055176A1/en not_active Ceased
- 1998-05-29 PL PL98337450A patent/PL337450A1/xx unknown
- 1998-05-29 EP EP98928726A patent/EP0986417A1/en not_active Withdrawn
- 1998-05-29 HU HU0001919A patent/HUP0001919A3/hu unknown
-
1999
- 1999-11-24 IS IS5271A patent/IS5271A/is unknown
- 1999-12-03 NO NO995962A patent/NO995962L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| BR9809552A (pt) | 2000-06-20 |
| CA2291612A1 (en) | 1998-12-10 |
| IS5271A (is) | 1999-11-24 |
| JP2002502290A (ja) | 2002-01-22 |
| AR012857A1 (es) | 2000-11-22 |
| HUP0001919A3 (en) | 2000-12-28 |
| NO995962D0 (no) | 1999-12-03 |
| HUP0001919A2 (hu) | 2000-10-28 |
| KR20010049181A (ko) | 2001-06-15 |
| NO995962L (no) | 1999-12-03 |
| IL133041A0 (en) | 2001-03-19 |
| CN1263476A (zh) | 2000-08-16 |
| EE9900563A (et) | 2000-06-15 |
| SE9702147D0 (sv) | 1997-06-05 |
| PL337450A1 (en) | 2000-08-14 |
| TR199902959T2 (xx) | 2000-04-21 |
| ZA984537B (en) | 1998-12-07 |
| EP0986417A1 (en) | 2000-03-22 |
| AU8045398A (en) | 1998-12-21 |
| WO1998055176A1 (en) | 1998-12-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5474535A (en) | Dosage and inserter for treatment of erectile dysfunction | |
| JP3477197B2 (ja) | 勃起機能障害 | |
| WO2003013641A3 (en) | Side-exit catheter and method for its use | |
| CA2407912A1 (en) | Method and apparatus for diagnostic and therapeutic agent delivery | |
| US11541043B2 (en) | Low concentration delivery of an ergoline derivative for treatment of a headache | |
| CN114767389A (zh) | 药物递送装置 | |
| SK165999A3 (en) | A transurethral device | |
| SK133499A3 (en) | A transurethral device | |
| US20060100566A1 (en) | Apparatus and method for the treatment of dysmenorrhea | |
| US20220161010A1 (en) | Drug delivery and administration device | |
| CZ432199A3 (cs) | Transuretrální zařízení | |
| Schittecatte et al. | Growth hormone response to clonidine in male patients with panic disorder untreated by antidepressants | |
| WO2003097150A3 (en) | Safety device for catheter guide needle | |
| CZ360699A3 (cs) | Transuretrální zařízení a kryt pro ně | |
| RU2000100329A (ru) | Трансуретральное устройство | |
| Fritsche et al. | Intracavernous, transurethral, and topical therapies for erectile dysfunction in the era of oral pharmacotherapy: salvaging first-line therapy failures with combination therapies | |
| JP2003515395A (ja) | 家畜に駆虫薬を注射するための装置 | |
| TH32570A (th) | อุปกรณ์สวนท่อปัสสาวะ | |
| ES2155740A1 (es) | Dispositivo intrauretral para el tratamiento de la disfuncion erectil. | |
| MXPA99009224A (en) | A transurethral device |